Adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex versus BCG therapy in patients with high risk nonmuscle-invasive bladder cancer

Adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex versus BCG therapy in patients with high risk nonmuscle-invasive bladder cancer

Objective: to compare recurrence rate, progression rate and recurrence-free survival in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) after adjuvant intravesical chemotherapy (IVCT) with titanium glycerosolvate aquacomplex (TGA) versus intravesical BCG therapy.Material and metho...

Full description

Bibliographic Details
Main Authors: A. V. Zamyatin, V. O. Mager, A. S. Orlov, K. A. Il'in, S. E. Zavatskiy, D. A. Kovalenko, V. P. Shcheglova, S. A. Berzin, A. V. Zyryanov
Format: Article
Language:Russian
Published: ABV-press 2020-11-01
Series:Onkourologiâ
Subjects:
adjuvant intravesical chemotherapy
hydrogel
titanium glycerosolvate aquacomplex
intravesical bcg
high risk non-muscle invasive bladder cancer
propensity score matching
pseudo randomization
Online Access:https://oncourology.abvpress.ru/oncur/article/view/1308

Internet

https://oncourology.abvpress.ru/oncur/article/view/1308

Similar Items